Application of optic coherence tomography as a screening in prevention and control of diabetic retinopathy

Background. Diabetes mellitus is a leading cause of death, disability, and adult blindness from diabetic retinopathy worldwide. Recent studies have provided a better understanding of the disease process and have opened new doors for prevention and treatment. The aim of our study is to evaluate the e...

Full description

Saved in:
Bibliographic Details
Main Authors: Radina Kirkova (Author), Ivan Tanev (Author), Tzvetomir Dimitrov (Author), Tanya Dimitrova (Author), Vidin Kirkov (Author)
Format: Book
Published: Pensoft Publishers, 2024-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3a86ee0b2df543689977489b44a4c63d
042 |a dc 
100 1 0 |a Radina Kirkova  |e author 
700 1 0 |a Ivan Tanev  |e author 
700 1 0 |a Tzvetomir Dimitrov  |e author 
700 1 0 |a Tanya Dimitrova  |e author 
700 1 0 |a Vidin Kirkov  |e author 
245 0 0 |a Application of optic coherence tomography as a screening in prevention and control of diabetic retinopathy 
260 |b Pensoft Publishers,   |c 2024-06-01T00:00:00Z. 
500 |a 10.3897/pharmacia.71.e123918 
500 |a 2603-557X 
520 |a Background. Diabetes mellitus is a leading cause of death, disability, and adult blindness from diabetic retinopathy worldwide. Recent studies have provided a better understanding of the disease process and have opened new doors for prevention and treatment. The aim of our study is to evaluate the effectiveness of the current screening methods for prevention and control of dia-betic retinopathy and to create a program for optimization. Material and methods. We included 123 patients with type 1 and type 2 diabetes mellitus. Clinical characteristics of the population were collected from patients' files. The HbA1c level was measured. Results. Among examined cohort group - 45% are with diabetes type 1 and 55% with diabetes type 2. In distribution by gender the prevalence is for males. The biggest part of the participants in our study is in the age group 45-66 years old. In 94% of the patients the duration of the disease is between 3-10 years. 22% of the pa-tients are with non-proliferative diabetic retinopathy (NPDR), 45% with proliferative diabetic retinopathy (PDR) and 33% with diabetic macular edema (DME). Conclusion. Our opinion is that the current ophthalmologic devices, such as fundus cameras and OCT (multimodal imaging), should be incorporated in the process of screening for diabetic retinopathy due to the detailed information they provide and the short time to perform the procedure. 
546 |a EN 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmacia, Vol 71, Iss , Pp 1-9 (2024) 
787 0 |n https://pharmacia.pensoft.net/article/123918/download/pdf/ 
787 0 |n https://pharmacia.pensoft.net/article/123918/download/xml/ 
787 0 |n https://pharmacia.pensoft.net/article/123918/ 
787 0 |n https://doaj.org/toc/2603-557X 
856 4 1 |u https://doaj.org/article/3a86ee0b2df543689977489b44a4c63d  |z Connect to this object online.